European Journal of Integrative Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2019-07-30 Yuen

审稿速度:1.0 | 投稿命中率:50.0
经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019

195 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2022-01-19 ms5000000251507332

审稿速度:1.0
偏重的研究方向：针灸
经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？

48 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2022-02-19 12415e1cm11暂无昵称

该期刊可以双通讯吗？

42 0

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2022-01-03 ms9000000913432311

投稿过程有些复杂

54 0

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2021-12-28 小动量

文章应该如何上传？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2021-08-01 148ca0a9m16暂无昵称

这个杂志收meta 的protocol嘛

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2020-11-19 1465a4d3m45(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：文献研究;心血管疾病
经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。

107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

148 0

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2019-02-17 12536e50m64暂无昵称

临床case report接收吗月貌花容 2017-07-12 发表::
审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表:
中午投稿，下午被拒，快的我有点难受。

月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。

136 0

[GetPortalCommentsPageByObjectIdResponse(id=574189, encodeId=72425e4189f6, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：Sent to Production 24 Jul 2019 Accept: 24 July 2019 Minor Revise: 23 July 2019 Major Revise: 09 July 2019 Major Revise: 13 May 2019 Received: 18 April 2019, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645d1627020, createdName=Yuen, createdTime=Tue Jul 30 00:00:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186050, encodeId=5b9e11860508c, content=审稿速度:1.0 偏重的研究方向：针灸 经验分享：审稿编辑让我提供这个，the acknowledgment for the manuscript file，有大佬知道这个是什么嘛？我没在官网找到相应模版，有人指导嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68db5683736, createdName=ms5000000251507332, createdTime=Wed Jan 19 15:51:29 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194948, encodeId=b86e119494828, content=该期刊可以双通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Feb 19 00:13:40 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180000, encodeId=33701180000af, content=投稿过程有些复杂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Mon Jan 03 13:57:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103736, encodeId=c6bc1103e36c1, content=文章应该如何上传？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004459, encodeId=7c15100445984, content=这个杂志收meta 的protocol嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2a25330277, createdName=148ca0a9m16暂无昵称, createdTime=Sun Aug 01 20:08:37 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900443, encodeId=41be9004435f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：文献研究;心血管疾病 经验分享：投稿之后1个星期之内会送审，1-2个月会给审稿回复，审稿意见给的也很详细，版面费方面分：开放获取（需要版面费）和订阅获取（不需要版面费）两种，可自行选择，总体来说还算友好了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4adc5132040, createdName=1465a4d3m45(暂无昵称), createdTime=Thu Nov 19 12:08:30 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578842, encodeId=0c105e884244, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566867, encodeId=62c456686efe, content=临床case report接收吗月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。月貌花容 2017-07-12 19:34:00 发表: 中午投稿，下午被拒，快的我有点难受。, beContent=月貌花容 2017-07-12 发表:: 审稿时间：约1个月 SCI(2016)：0.801 SCI(2015)：0.769 SCI(2014)：0.777 中午投稿，下午被拒，快的我有点难受。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b22548078, createdName=12536e50m64暂无昵称, createdTime=Sun Feb 17 00:00:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564201, encodeId=bc17564201a8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志临床研究需要原始数据上交么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34c52092377, createdName=479609766_59734177, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=)]

2018-12-09 479609766_59734177

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这个杂志临床研究需要原始数据上交么

185 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务